Servicios Personalizados
Revista
Articulo
Indicadores
- Citado por SciELO
- Accesos
Links relacionados
- Similares en SciELO
Compartir
Gaceta médica de México
versión On-line ISSN 2696-1288versión impresa ISSN 0016-3813
Resumen
MANZUR-SANDOVAL, Daniel et al. Use of pulmonary ultrasound to predict in-hospital mortality in patients with COVID-19 infection. Gac. Méd. Méx [online]. 2021, vol.157, n.3, pp.261-266. Epub 13-Sep-2021. ISSN 2696-1288. https://doi.org/10.24875/gmm.20000768.
Introduction:
Lung ultrasound (LUS) implementation in patients with COVID-19 can help to establish the degree of pulmonary involvement, evaluate treatment response and estimate in-hospital outcome.
Objective:
To evaluate the application of LUS in patients with COVID-19 infection to predict in-hospital mortality.
Methods:
The study was carried out from April 1 to August 1, 2020 in patients with COVID-19 infection admitted to the Intensive Care Unit. Lung evaluation was carried out by physicians trained in critical care ultrasonography.
Results:
Most patients were males, median age was 56 years, and 59 % required mechanical ventilation. In-hospital mortality was 39.4 %, and in those with a LUS score ≥ 19, mortality was higher (50 %). The multiple logistic regression model showed that a LUS score ≥ 19 was significantly associated with mortality (hazard ratio = 2.55, p = 0.01).
Conclusions:
LUS is a safe and fast clinical tool that can be applied at bedside in patients with COVID-19 infection to establish the degree of parenchymal involvement and predict mortality.
Palabras llave : COVID 19; Lung ultrasound; Mortality.